Abstract:Spinal cord injury (SCI) can result in irreversible damage, leading to lifelong paralysis for affected individuals. Microglia's dual impact on neuronal regeneration after SCI, driven by their distinct roles at different stages, merits further study. We conducted a bioinformatic analysis of single-cell transcriptomes (scRNA), spatial transcriptomic (ST) data, and bulk RNA-seq data from Gene Expression Omnibus (GEO) datasets. The data were processed using R packages such as "Seurat", "DESeq2" ,limma; and "GSVA." Additionally, we utilized Gene Set Enrichment Analysis (GSEA) and the Enrichr web servers. Analysis of single-cell data and spatial transcriptomics has revealed notable changes in the microglial cell landscape in SCI. These changes encompass the inhibition of innate microglial cells, while reactive microglial cells exhibit pronounced reactive hyperplasia. Moreover, the TGFbeta signaling pathway plays a crucial role in regulating the migration of innate microglial cells to enhance SCI recovery. However, reactive microglial cells exhibiting high Trem2 expression contribute to the neuroinflammatory response and can effectively modulate neural cell death in SCI. In particular, inhibiting Trem2 in reactive microglial cells not only reduces inflammation but also mitigates spinal cord injury, and enhancing the TGFbeta signaling pathway. What's more, the use of iPSC-derived microglial cells, which have demonstrated their capacity to augment the potential for replacing the functions of naive microglial cells, iPSC-derived microglia have the potential to replace the functions of naive microglial cells, holds significant promise in addressing SCI. Therefore, we posit that the engineering of microglial cells to promote the SCI recovery. The approach of inhibiting Trem2-mediated neuroinflammatory responses and transplanting iPSC-derived microglia with long-term TGFbeta stimulation may offer potential improvements in SCI recovery.

Research Progress on Treating Spinal Cord Injury by Modulating the Phenotype of Microglia

Transplantation Strategies for Spinal Cord Injury Based on Microenvironment Modulation

Single-cell Sequencing Reveals the Optimal Time Window for Anti-Inflammatory Treatment in Spinal Cord Injury

Inflammation & apoptosis in spinal cord injury.

Current Knowledge of Microglia in Traumatic Spinal Cord Injury

Advances in the research of the role of macrophage/microglia polarization-mediated inflammatory response in spinal cord injury

Effects of astrocytes and microglia on neuroinflammation after spinal cord injury and related immunomodulatory strategies

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review

The Polarization States of Microglia in Tbi: A New Paradigm for Pharmacological Intervention

Microglia: a promising therapeutic target in spinal cord injury

Engineering Microglial Cells to Promote Spinal Cord Injury Recovery

Implications of microglial heterogeneity in spinal cord injury progression and therapy

Biomaterials delivery strategies to repair spinal cord injury by modulating macrophage phenotypes

Microenvironments‐Modulated Biomaterials Enhance Spinal Cord Injury Therapy

Anti-inflammatory Effect of Stem Cells Against Spinal Cord Injury Via Regulating Macrophage Polarization

Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar

Mechanism of mesenchymal stem cells in spinal cord injury repair through macrophage polarization

Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury

Spinal cord injury: molecular mechanisms and therapeutic interventions

Progression of mesenchymal stem cell regulation on imbalanced microenvironment after spinal cord injury